Ortho Clinical Diagnostics to Participate in September Investor Conferences
September 03 2021 - 9:00AM
Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the
world’s largest pure-play in vitro diagnostics (IVD) companies,
today announced that members of its management team are scheduled
to participate in two upcoming investor conferences:
- Morgan Stanley 19th Annual Global Healthcare Conference
Fireside chat scheduled for Thursday, September 9, 2021 at
2:00pm ET
- H.C. Wainwright 23rd Annual Global Investment Conference
Pre-recorded presentation will be available Monday, September
13, 2021 at 7:00am ET
Interested parties can access a live webcast and replay of each
presentation on the “Investors” page of the company’s website at
https://ir.orthoclinicaldiagnostics.com/, under the “Events”
section of the page. Management will also host individual meetings
with investors at both conferences.
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics Holdings plc (“Ortho”) (Nasdaq: OCDX)
is one of the world’s largest pure-play in vitro diagnostics (IVD)
companies dedicated to transforming patient care.
More than 800,000 patients across the world are impacted by
Ortho’s tests each day. Because Every Test Is A Life™, Ortho
provides hospitals, hospital networks, clinical laboratories and
blood banks around the world with innovative technology and tools
to ensure test results are fast, accurate and reliable. Ortho's
customized solutions enhance clinical outcomes, improve efficiency,
overcome lab staffing challenges and reduce costs.
From launching the first product to determine Rh+ or Rh- blood
type, developing the world’s first tests for the detection of
antibodies against HIV and hepatitis C, introducing patented
dry-slide technology, and marketing the first U.S. Food and Drug
Administration-authorized high-volume antibody and antigen tests
for COVID-19, Ortho has been a pioneering leader in the IVD space
for over 80 years.
The company is powered by Ortho Care® Service and Support, an
award-winning, holistic program that ensures best-in-class
technical, field, and remote service and inventory support to
laboratories in more than 130 countries and territories around the
globe.
For more information, visit Ortho’s social media channels:
LinkedIn, Twitter, Facebook and YouTube.
Investors:
IR@orthoclinicaldiagnostics.com
Media:
media@orthoclinicaldiagnostics.com
Ortho Clinical Diagnostics (NASDAQ:OCDX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ortho Clinical Diagnostics (NASDAQ:OCDX)
Historical Stock Chart
From Jul 2023 to Jul 2024